A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

China

Affiliated Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang

Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality